Stockreport

Lexeo Therapeutics Announces License Agreement to Accelerate Development of LX2006 for the Treatment of Friedreich Ataxia Cardiomyopathy [Yahoo! Finance]

Lexeo Therapeutics, Inc.  (LXEO) 
PDF trial of gene therapy candidate AAVrh.10hFXN (LX2006) to support regulatory discussions Together with Lexeo Therapeutics' ongoing study of LX2006, a total of 11 partic [Read more]